BioCentury
ARTICLE | Company News

PDL BioPharma management update

August 18, 2008 7:00 AM UTC

PDL BioPharma Inc. (NASDAQ:PDLI), Redwood City, Calif. Business: Cancer, Autoimmune, Antibodies Resigned: Richard Murray as EVP and CSO, effective Sept. 5 ...